CClinicalTrials.gg
RecruitingNCT07600931Updated May 22, 2026

Assessment of LVOT VTI in Healthy Volunteers

An observational study in Hemodynamic Assessment, Bedside Ultrasonography and Point of Care Ultrasound (POCUS), sponsored by Medical University of Warsaw. Recruiting at 1 site in Poland. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-22.

Sponsored by Medical University of Warsaw · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
30
Ages
18 Years and older
Sex
All
01

Study summary

Healthy subjects will have transthoracic echocardiography evaluation of Left Ventricular Outflow Tract Velocity-Time Integral (LVOT VTI) performed by operators after brief training.

Read the detailed description

VTI is an echocardiographic parameter used to assess a patient's hemodynamic status. VTI reflects the distance traveled by blood ejected from the left ventricle during systole, enabling non-invasive estimation of key circulatory parameters, including stroke volume (SV) and cardiac output (CO).

Evidence suggests that even brief training combined with expert supervision allows novice operators to obtain measurements comparable to those of experienced clinicians, indicating a steep learning curve.

In this study, operators with minimal training will perform transthoracic echocardiography and measure LVOT VTI (in cm) in healthy volunteers. These measurements will subsequently be compared with those obtained by an experienced operator.

Aim: To assess the equivalence of LVOT VTI measurements obtained by minimally trained operators compared with those acquired by expert operators, as well as to evaluate inter-operator variability among participants. The findings may support the development and optimization of training programs for physicians in point-of-care echocardiography.

02

Conditions studied

  • Hemodynamic Assessment
  • Bedside Ultrasonography
  • Point of Care Ultrasound (POCUS)

Keywords

  • Hemodynamic Assessment
  • Velocity-Time Integral
  • Bedside Ultrasonography
  • Point of care ultrasound
  • Critical care
03

In context

Lead sponsor

Medical University of Warsaw is the lead sponsor of 316 studies on the registry; 87 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Healthy volunteers without known structural heart disease, no history of atrial fibrillation, no aortic valve disease, and not pregnant.

Inclusion criteria

  • Age > 18 years,
  • Medical student at Medical University of Warsaw or licensed physician.

Exclusion criteria

Exclusion Criteria:

  • Age \< 18 years,
  • Prior experience in performing cardiac ultrasound examinations, including acquisition of apical five- and three-chamber views and Doppler measurements of LVOT VTI.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
30 participants (estimated)
Patient registry
No

Groups and cohorts

  • Operator without experience in cardiac ultrasound examinations

    Medical student at Medical University of Warsaw or licensed physician

    Other: transthoracic echocardiography

Interventions

  • Othertransthoracic echocardiography

    After brief training, operators will measure Velocity-Time Integral (in cm) of Left Ventricular Outflow Tract Obstruction in healthy volunteers.

06

What researchers measure

Primary outcomes

  1. Agreement between VTI measurements obtained by study participants and those obtained by an experienced operator.

    Assessment using correlation coefficient, the intraclass correlation coefficient (ICC), and Bland-Altman analysis.

    Time frame: Day 2

Secondary outcomes

  1. Assessment of inter-observer variability (inter-operator variability) of VTI measurements performed by fellows.

    Assessment using correlation coefficient, the intraclass correlation coefficient (ICC), and Bland-Altman analysis.

    Time frame: Day 2

  2. Assessment of intra-observer variability (intra-operator variability) of VTI measurements.

    Assessment using correlation coefficient, the intraclass correlation coefficient (ICC), and Bland-Altman analysis.

    Time frame: Day 2

  3. Assessment of time required to obtain a VTI measurement by participants.

    Time (in minutes and seconds) from probe placement to successful acquisition of a valid VTI measurement.

    Time frame: Day 2

07

Study locations

1 of 1 sites recruiting
  • Medical University of Warsaw
    Warsaw, Poland
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07600931
Lead sponsor
Medical University of Warsaw
Responsible party
Sponsor
First posted
May 22, 2026
Start date
May 11, 2026 (estimated)
Primary completion
Dec 30, 2026 (estimated)
Completion
Jan 2027 (estimated)
Last update
May 22, 2026

Study contacts

Julia Trzebicka, MD
principal investigator · Medical University of Warsaw

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion